March Social Media Round-Up—2025 Annual Review, World’s Most Ethical Companies, and More
Spring has sprung! At Pfizer, we’re celebrating the changing seasons with exciting updates across our social channels. Catch up on other updates.
Pfizer’s HYMPAVZI Receives Positive CHMP Opinion for Once-Weekly Treatment of Adults and Adolescents with Hemophilia A or B with Inhibitors
NEW YORK, March 27, 2026 –Pfizer Inc. (NYSE: PFE)announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for HYMPAVZI® (marstacimab) to expand the approved indication to include patients 12 years of age and older weighing at least 35 kg with hemophilia A (congenital factor VIII [FVIII] deficiency) with FVIII inhibitors, or hemophilia B (congenital factor IX [FIX] deficiency) with FIX inhibitors.
Pfizer Among World’s Most Ethical Companies for 5th Straight Year
We are proud to share some news: for the fifth straight year, Pfizer has been recognized as one of the World’s Most Ethical Companies®. This recognition from Ethisphere reflects our continued commitment to integrity, transparency, and doing what’s right for patients, partners, and society.
CEO Albert Bourla Reflects on Pfizer’s Year of Bold Moves and Relentless Innovation in 2025 Annual Review
2025 was a typically busy year for Pfizer, one of strong performance, disciplined execution and bold moves that position us for future growth and lasting impact for patients around the world as we continue to pursue our mission of making breakthroughs that change people’s lives.
Self -Care for Caregivers
Caregivers play remarkable and invaluable roles in our communities. They support children, parents, grandparents, spouses, neighbors, and friends.
February Social Media Round-Up—World Cancer Day, Science Will Win, and More
The groundhog may have predicted six more weeks of winter, but here at Pfizer we’re predicting blue skies ahead as we wrap up another great month. See what else we’ve been up to.
The 6th Season of 'Science Will Win' Takes on Cancer
It all starts with education, which is why we’re excited to announce that the new season of our award-winning flagship podcast, Science Will Win, which launched today, is tackling cancer head-on with the help of expert doctors and scientists. Now in its sixth season, Science Will Win ranks among the top 1% of all podcasts thanks to its educational and provocative explorations of the latest in science and medicine.
Pfizer Global Supply (PGS) — A Manufacturing Powerhouse
At Pfizer, we’re relentless in our pursuit of breakthroughs that change patients’ lives. But delivering medicines and vaccines worldwide is not a simple undertaking.
Here’s How Pfizer is Fighting Cancer – and How You Can, Too
Every year on the fourth day of February, the world comes together to raise awareness of cancer and to encourage its prevention, detection, and treatment. It’s World Cancer Day.
January Social Media Round-Up—2026 Strategic Priorities, Clinical Trials, and More
The new year is off to an exciting start here at Pfizer! Check out the latest updates.